Search

Scholarly Works (1 results)

Article
Peer Reviewed

Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study

Feng, Sandy;
Klintmalm, GB;
Lake, JR;
Vargas, HE;
Wekerle, T;
Agnes, S;
Brown, KA;
Nashan, B;
Rostaing, L;
Meadows-Shropshire, S

UC San Francisco Previously Published Works (2014)

This exploratory phase II study evaluated the safety and efficacy of belatacept in de novo adult liver transplant recipients. Patients were randomized (N=260) to one of the following immunosuppressive regimens: (i) basiliximab+belatacept high dose [HD]+myc